Siemens Healthineers (SMMNY) Stock Price, News & Analysis

Company Overview

Siemens Healthineers AG is a Germany-based medical technology company that develops and supplies products, services and digital solutions for healthcare providers. Its portfolio supports medical imaging, laboratory diagnostics, cancer treatment, minimally invasive procedures and related clinical workflows.

The company’s imaging business offers magnetic resonance imaging, computed tomography, molecular imaging, X-ray and ultrasound systems. Its diagnostics activities include laboratory testing, point-of-care testing and diagnostic IT solutions. Through its advanced therapies and cancer care businesses, Siemens Healthineers provides image-guided treatment systems, angiography equipment, radiation oncology solutions and associated software and services.

Siemens Healthineers serves hospitals, clinics, laboratories and other healthcare organizations internationally, with operations and customers across major markets in Europe, the Americas, Asia and other regions. The company was established as Siemens’ healthcare business and became a separately listed company in 2018. Its acquisition of Varian in 2021 expanded its oncology and radiation therapy capabilities. Siemens Healthineers is headquartered in Erlangen, Germany, and is led by President and Chief Executive Officer Bernd Montag.

Key Stats

• Today's Range: $21.39 to $21.64
• 50-Day Range: $21.06 to $23.50
• 52-Week Range: $19.20 to $28.92
• Volume: 50,261 shs
• Average Volume: 136,762 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Company Calendar

• Last Earnings: 5/07/2026
• Today: 10/08/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SMMNY
• CIK: N/A
• Web: www.siemens-healthineers.com
• Phone: (949) 913-1840
• Fax: N/A
• Employees: 74,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A